Skip to main navigation
Skip to search
Skip to main content
Hong Kong Baptist University Home
Help & FAQ
Home
Scholars
Departments / Units
Research Output
Projects / Grants
Prizes / Awards
Activities
Press/Media
Student theses
Datasets
Search by expertise, name or affiliation
Fangfei LI public CV
View Scopus Profile
Fangfei LI, Prof
Assistant Professor
,
Chinese Medicine - Teaching and Research Division
https://orcid.org/0000-0001-8281-6115
Email
fangfeili
hkbu.edu
hk
Accepting PhD Students
2011
2025
Research activity per year
Overview
Fingerprint
Network
Projects / Grants
(5)
Research Output
(63)
Prizes / Awards
(2)
Activities
(10)
Press/Media
(3)
Similar Scholars
(6)
Fingerprint
Dive into the research topics where Fangfei LI is active. Topic labels come from the works of this scholar. Together they form a unique fingerprint.
Sort by:
Weight
Alphabetically
Keyphrases
Aptamer
100%
Ruthenium Complexes
90%
Dinuclear
90%
Pancreatic Ductal Adenocarcinoma
66%
Antimicrobial
63%
Triple-negative Breast Cancer
52%
Phen
51%
Escherichia Coli
49%
Antimicrobial Activity
46%
Ruthenium
45%
Staphylococcus Aureus
44%
Tumor Microenvironment
42%
Osteoclast
41%
Paclitaxel
39%
Osteosarcoma
39%
Non-small Cell Lung Cancer (NSCLC)
39%
Sclerostin
39%
Pancreatic Cancer
39%
Cancer-associated Fibroblasts
39%
In Cancer
39%
Targeted Drug Delivery
36%
Eukaryotic Cells
34%
Pseudomonas Aeruginosa (P. aeruginosa)
33%
Inflammation
31%
Methicillin-resistant S. Aureus
31%
Bone Formation
30%
Minimum Inhibitory Concentration
28%
PARP Inhibitor (PARPi)
27%
Osteoblastic
26%
Programmed Death-ligand 1 (PD-L1)
26%
Nucleolin Aptamer
26%
MiR-214-3p
26%
Breast Cancer Bone Metastasis
26%
Therapeutic Genome Editing
26%
Oligonuclear
26%
Cucurbits
26%
Exosomal
26%
Molecular Understanding
26%
Iridium Complex
26%
Inflammatory Genes
26%
Gene Network
26%
1,10-Phenanthroline
25%
Tumor Growth
25%
Metal Center
24%
Therapeutic Strategies
24%
Tumor
24%
Therapeutic Agents
23%
Metal Complexes
23%
MicroRNA
22%
Bacterial Membrane
22%
Pharmacology, Toxicology and Pharmaceutical Science
Ruthenium Complex
76%
Aptamer
73%
Antiinfective Agent
69%
Malignant Neoplasm
58%
Neoplasm
55%
Staphylococcus aureus
48%
Escherichia coli
42%
Tumor Growth
40%
Osteosarcoma
39%
Antimicrobial Agent
35%
Targeted Drug Delivery
30%
Non Small Cell Lung Cancer
30%
Breast Cancer
30%
Nucleic Acid
27%
Nucleolin
26%
Triple Negative Breast Cancer
26%
Bone Metastasis
26%
Sclerostin
26%
Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase 1
26%
Cucurbitaceae
26%
Bone Disease
26%
Pancreas Cancer
26%
Paclitaxel
22%
Pseudomonas aeruginosa
20%
Lung Metastasis
20%
Meticillin
19%
Tumor Microenvironment
19%
Flow Cytometry
18%
Lung Cancer
18%
Pharmacokinetic
18%
Chemotherapy
18%
Oligonucleotide
16%
Minimum Inhibitory Concentration
16%
Cancer Growth
16%
Drug Delivery System
14%
Binding Site
14%
Taraxasterol
13%
Rheumatoid Arthritis
13%
Inflammatory Arthritis
13%
Bone Erosion
13%
Leflunomide
13%
Drug Discovery
13%
microRNA 214
13%
Ezrin
13%
Programmed Death 1 Ligand 1
13%
Controlled Drug Release
13%
Biological Activity
13%
Carcinoma
13%
Tumor Necrosis Factor Receptor Associated Factor 3
13%
Retinoic Acid
13%
Medicine and Dentistry
Pancreas Adenocarcinoma
52%
Aptamer
44%
Cancer Associated Fibroblast
39%
Tumor Microenvironment
32%
Bone Metastasis
26%
Breast Cancer
26%
Genome Editing
26%
Pancreas Cancer
26%
Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase 1
26%
Osteosarcoma
26%
Malignant Neoplasm
24%
Osteoclast
19%
Chemokine
18%
Lung Metastasis
18%
microRNA
18%
Signaling Protein
17%
Targeted Therapy
16%
Metastatic Carcinoma
16%
Osteolysis
16%
Tumor Cell
16%
Clustered Regularly Interspaced Short Palindromic Repeat
15%
Cas9
15%
Cancer Treatment
15%
Cell Signaling Pathway
15%
Ossification
15%
Cancer Cell
13%
Bone Morphogenetic Protein
13%
Programmed Death-Ligand 1
13%
Triple Negative Breast Cancer
13%
Molecular Therapy
13%
Tumor Necrosis Factor Receptor Associated Factor 3
13%
Vasculotropin A
13%
Nuclease
13%
Disorders of Calcium Metabolism
13%
Phosphate Metabolism
13%
Carcinoma
13%
High Fat Food
13%
Hydroxysteroid Dehydrogenase
13%
Bone Disease
13%
Metabolomics
13%
Proteomics
13%
Osteoclast Differentiation Factor
13%
Paclitaxel
13%
Chondrocyte
13%
Osteoarthritis
13%
Osteoporosis
13%
Atrophic Gastritis
13%
Drug Therapy
13%
microRNA 214
13%
Nucleic Acid
13%
